Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging

Archives of Neurology

Volumn 63, Issue 2, 2006, Pages 288-290

  Lewis, Aaron M ^a   Yu, Melissa ^a   DeArmond, Stephen J ^b   Dillon, William P ^a   Miller, Bruce L ^a   Geschwind, Michael D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADULT; ARTICLE; ATAXIA; AUTOPSY; BLURRED VISION; CADAVER; CASE REPORT; CEREBELLUM; CREUTZFELDT JAKOB DISEASE; DIFFUSION; EARLY DIAGNOSIS; HUMAN; HYPOPHYSIS; IATROGENIC DISEASE; IMAGING; MALE; NEUROLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT; PRION DISEASE; PRIORITY JOURNAL;

ADULT; CADAVER; CEREBELLUM; CREUTZFELDT-JAKOB SYNDROME; DIFFUSION MAGNETIC RESONANCE IMAGING; DRUG CONTAMINATION; HUMAN GROWTH HORMONE; HUMANS; IATROGENIC DISEASE; MALE;

EID: 32944465953     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.63.2.288     Document Type: Article

References (16)

1. Koch TK, Berg BO, De Armond SJ, Gravina RF. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism: possible relation to the administration of cadaveric human growth hormone. N Engl J Med. 1985;313:731-733.
2. Gibbs CJ Jr, Joy A, Heffner R, et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med. 1985;313:734-738.
3. Powell-Jackson J, Weller RO, Kennedy P, Preece MA, Whitcombe EM, Newsom-Davis J. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet. 1985;2:244-246.
4. Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull. 2003;66:255-265.
5. Burdette JH, Elster AD, Ricci PE. Acute cerebral infarction: quantification of spindensity and T2 shine-through phenomena on diffusion-weighted MR images. Radiology. 1999;212:333-339.
6. Brown P, Preece M, Brandel JP, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology. 2000;55:1075-1081.
7. Fradkin JE, Schonberger LB, Mills JL, et al. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA. 1991;265:880-884.
8. Alperovitch A, Zerr I, Pocchiari M, et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease [published correction appears in Lancet. 2000;355:72]. Lancet. 1999;353:1673-1674.
9. Brandel JP, Preece M, Brown P, et al. Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet. 2003;362:128-130.
10. Oppenheim C, Zuber M, Galanaud D, et al. Spectroscopy and serial diffusion MR findings in hGH-Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2004;75:1066-1069.
11. Caboclo LO, Huang N, Lepski GA, et al. Iatrogenic Creutzfeldt-Jakob disease following human growth hormone therapy: case report. Arq Neuropsiquiatr. 2002;60:458-461.
12. Poon MA, Stuckey S, Storey E. MRI evidence of cerebellar and hippocampal involvement in Creutzfeldt- Jakob disease. Neuroradiology. 2001;43:746-749.
13. Brownell B, Oppenheimer DR. An ataxic form of subacute presenile polioencephalopathy (Creutzfeldt-Jakob disease). J Neurol Neurosurg Psychiatry. 1965;28:350-361.
14. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology. 2004;63:443-449.
15. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 2005;26:1551-1562.
16. Billette de Villemeur T, Deslys JP, Pradel A, et al. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology. 1996;47:690-695.